Pregnancy Outcomes in Women With Primary Hyperparathyroidism

被引:80
|
作者
Hirsch, Dania [1 ,2 ,3 ]
Kopel, Vered [4 ]
Nadler, Varda [4 ]
Levy, Sigal [5 ,6 ]
Toledano, Yoel [3 ,7 ]
Tsvetov, Gloria [1 ,2 ,3 ]
机构
[1] Beilinson Med Ctr, Rabin Med Ctr, Inst Endocrinol, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel
[3] Maccabi Hlth Care Serv, IL-6812509 Tel Aviv, Israel
[4] Maccabi Hlth Care Serv, Cent Lab, IL-6812509 Tel Aviv, Israel
[5] Acad Coll Tel Aviv Yaffo, IL-6818211 Tel Aviv, Israel
[6] Tel Aviv Univ, Sackler Fac Exact Sci, IL-6997801 Tel Aviv, Israel
[7] Helen Schneider Hosp Women, Rabin Med Ctr, Div Maternal Fetal Med, IL-49100 Petah Tiqwa, Israel
来源
关键词
CALCIUM; DISORDERS;
D O I
10.1210/jc.2015-1110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Primary hyperparathyroidism (PHPT) during pregnancy may pose considerable risks to mother and fetus. This study examined pregnancy outcomes in women with gestational PHPT in relation to clinical and laboratory parameters. Design: This study was designed as a retrospective case series. Methods: The study group included 74 women aged 20-40 years who were diagnosed with PHPT after a finding of serum calcium >= 10.5 mg/dL on routine screening at a health maintenance organization (2005-2013) and who became pregnant during the time of hypercalcemia (124 pregnancies). Clinical and laboratory data were collected from the files. Pregnancy outcomes were compared with 175 normocalcemic pregnant women (431 pregnancies) tested during the same period. Results: The cohort represented 0.03% of all women of reproductive age tested for serum calcium during the study period. Abortion occurred in 12 of 124 pregnancies (9.7%), and other complications occurred in 19 (15.3%) with no statistically significant differences from controls. Hypercalcemia was first detected during pregnancy in 14 of 74 women (18.9%) and before pregnancy (mean, 33.4 +/- 29 mo) in 60. Serum calcium was measured antenatally in 57 of 124 pregnancies (46%); the mean level was 10.7 +/- 0.6 mg/dL (median, 10.6 mg/dL). Measurement of the serum PTH level (with consequent diagnosis of PHPT) was performed during the first studied pregnancy in 17 of 74 women (23%), before pregnancy (mean, 37.8 +/- 25.5 mo; median, 34 mo) in 23 (31.1%), and after delivery (mean, 54.7 +/- 45.7 mo; median, 35 mo) in 34 (45.9%). Forty-three women (58.1%) underwent parathyroidectomy, six during pregnancy, without maternal or fetal complications. No difference was found in abortion or any pregnancy-related complication between patients who subsequently underwent parathyroidectomy and those who did not. No significant correlation was found between calcium level during pregnancy and pregnancy outcomes. Conclusions: Serum calcium levels are usually only mildly elevated during pregnancy in women with PHPT. A significant proportion of cases go undiagnosed. Mild hypercalcemia in gestational PHPT is generally not associated with an increased risk of obstetrical complications.
引用
收藏
页码:2115 / 2122
页数:8
相关论文
共 50 条
  • [31] Primary hyperparathyroidism in pregnancy.
    Matejka, G
    Reynaud, I
    Petit, JM
    Pacaud, A
    Vaillant, G
    Verges, B
    Cougard, P
    Gouyon, JB
    Brun, JM
    ANNALES D ENDOCRINOLOGIE, 1996, 57 (01) : 77 - 80
  • [32] Primary hyperparathyroidism during pregnancy
    Dochez, Vincent
    Ducarme, Guillaume
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 291 (02) : 259 - 263
  • [33] Fertility and Pregnancy Outcomes in Primary Hyperparathyroidism: Observations From a Large Insured Population
    Sant, Vivek R.
    Zhou, Hui
    Zhou, Mengnan M.
    Adams, Annette L.
    Ryan, Denison S.
    Case, Samuel K.
    Seo, Young-Ji
    Haigh, Philip, I
    Janzen, Carla
    Yeh, Michael W.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [34] Primary hyperparathyroidism in pregnancy - a review of literature
    Komarowska, Hanna
    Brominska, Barbara
    Luftmann, Bartosz
    Ruchala, Marek
    GINEKOLOGIA POLSKA, 2017, 88 (05) : 270 - 275
  • [35] Primary hyperparathyroidism in pregnancy treated with bisphosphonates
    Tavares, Patricia
    Rocha, Gustavo
    Machado, Catarina
    Oliveira, Maria Joao
    GALICIA CLINICA, 2019, 80 (02): : 22 - 24
  • [36] Primary Hyperparathyroidism and Hypercalcemia During Pregnancy
    Ullah, M. Iftekhar
    Uwaifo, Gabriel I.
    Koch, Christian A.
    HORMONE AND METABOLIC RESEARCH, 2017, 49 (08) : 638 - 641
  • [37] Primary Hyperparathyroidism and Pregnancy: A Case Report
    Gorar, Suheyla
    Koc, Gonul
    Uc, Ziynet
    Dellal, Dilek
    Candan, Zehra
    Culha, Cavit
    Aral, Yalcin
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2011, 15 (01) : 16 - 19
  • [38] THE TREATMENT OF PRIMARY HYPERPARATHYROIDISM DURING PREGNANCY
    NUDELMANN, J
    DEUTSCH, A
    STERNBERG, A
    REISS, R
    BRITISH JOURNAL OF SURGERY, 1984, 71 (03) : 217 - 218
  • [39] Conservative management of primary hyperparathyroidism in pregnancy
    Perelli, Sarah
    Calogero, AldoE.
    Condorelli, Rosita A.
    Cannarella, Rossella
    Garofalo, Angela
    Brescia, Roberta
    Ciuni, Roberto
    Greco, Emanuela A.
    La Vignera, Sandro
    MINERVA ENDOCRINOLOGY, 2021, 46 (04): : 484 - 486
  • [40] PRIMARY HYPERPARATHYROIDISM, PREGNANCY, AND NEONATAL HYPOCALCEMIA
    KAPLAN, EL
    BURRINGTON, JD
    KLEMENTSCHITSCH, P
    TAYLOR, J
    DEFTOS, L
    SURGERY, 1984, 96 (04) : 717 - 722